Resource center
Find and download all our resources: technical and scientific papers, white papers, on-demand webinars, etc.
-
SeqOne DiagAI | Rare and hereditary diseases
Unleash the power of genomic insights with SeqOne DiagAI Discover a groundbreaking approach to rare and hereditary diseases through SeqOne DiagAI. Accelerate your understanding of [...]
-
SeqOne DiagAI | Maladies rares & héréditaires
Libérez le pouvoir des informations génomiques avec SeqOne DiagAI Découvrez une approche révolutionnaire des maladies rares et héréditaires grâce à SeqOne DiagAI. Accélérez votre compréhension [...]
-
Harnessing AI to improve diagnostic yield | ESHG 2023 Corporate satellite
Hear from industry experts who share valuable insights: Michael Blum will demonstrate how AI enhances rare disease diagnosis by leveraging joint analysis of exome (or [...]
-
Agilent Sureselect CD HRR17 panel validated with SeqOne HRD test
SeqOne workflow for maximum efficiency and compliance HRD is a key biomarker to identify ovarian cancer patients likely to respond to PARP inhibitor (PARPi) therapy. [...]
-
Unlock the power of Illumina’s TruSight™ Oncology 500 panel | Datasheet
The TruSight™ Oncology 500 panel has : Sensitivity and completeness RNA fusions and splices Immuno-oncology biomarker detection
-
SeqOne Platform for Oncology | Datasheet
SeqOne Platform for Oncology is a comprehensive software solution for analyzing somatic variants based on DNA, RNA or ctDNA. To provide support for diagnosis and [...]
-
The accurate, easy-to-deploy HRD test for labs | Datasheet English
The HRD test is a key biomarker to identify ovarian cancer patients likely to respond to PARP inhibitor (PARPi) therapy. SeqOne offers a clinically validated [...]
-
Le test HRD précis et facile à déployer en laboratoire | Datasheet Français
Le test HRD est un biomarqueur clé pour identifier les patientes atteintes d’un cancer de l’ovaire susceptibles de répondre au traitement par inhibiteur de PARP [...]
-
Efficient genomic variant prioritisation with SeqOne DiagAI
Supporting WES/WGS based clinical diagnosis with a variant-prioritization AI engine Rare diseases affect around 1 in 20 individuals, and 70% of them are caused by [...]
-
How to perform fast and accurate HRD testing while mitigating costs
HRD testing has never been easier thanks to our patent-pending scoring technology : Clinically validated performance Few inconclusive results Easy to deploy and operate Accurate, [...]
-
General Brochure English
From raw genomic data to actionable insights in an end-to-end pathway, our platform goes deeper to provide answers and improve patient outcomes, wether you are [...]
-
Learn about the latest thinking in HRD testing for ovarian cancer | Webinar Genome Web x SeqOne
With this video, discover new approaches that can reduce the number of inconclusive results and the amount of genomic material needed for your HRD tests. [...]